4//SEC Filing
Rosellini William 4
Accession 0001213900-18-005372
CIK 0001416172other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 8:11 PM ET
Size
9.4 KB
Accession
0001213900-18-005372
Insider Transaction Report
Form 4
Rosellini William
DirectorCHIEF EXECUTIVE OFFICER10% Owner
Transactions
- Award
OPTIONS
2018-02-28+900,000→ 900,000 totalExercise: $0.76From: 2018-03-01Exp: 2023-03-01→ COMMON STOCK (900,000 underlying) - Award
OPTIONS
2018-02-28+250,000→ 250,000 totalExercise: $0.76From: 2018-02-28Exp: 2022-02-28→ COMMON STOCK (250,000 underlying)
Footnotes (2)
- [F1]On February 28, 2018, and pursuant to the Issuer's 2016 Omnibus Incentive Plan, the Issuer granted to the Reporting Person an incentive stock option (the "Incentive Option") to purchase 250,000 shares of the Issuer's restricted common stock, at a price of $0.76 per share, as compensation for service as Chief Executive Officer of the Company. The option to purchase 125,000 shares of the Issuer's restricted common stock became immediately exercisable on the date of issue and the option to purchase the remaining 125,000 shares of the Issuer's restricted common stock vests on the anniversary of the grant date. The option to purchase shares of the Issuer's restricted common stock expire three (3) years from the date they become exercisable pursuant to the grant vesting schedule. The fair value of the options was determined to be $49,132 using the Black- Scholes Option Pricing Model.
- [F2]On February 28, 2018, and pursuant to the Issuer's 2016 Omnibus Incentive Plan, the Issuer granted to the Reporting Person a non-qualified stock option (the "NQS Option") to purchase 900,000 Issuer's restricted common stock at a price of $0.76 per share, as compensation for service as Chief Executive Officer of the Company. The NQS Option vests in equal monthly amounts of 37,500 beginning on March 1, 2018. The option to purchase Issuer's restricted common stock expire three (3) years from the date they become exercisable pursuant to the grant vesting schedule. The fair value of the options was determined to be $176,877 using the Black- Scholes Option Pricing Model.
Documents
Issuer
NEXEON MEDSYSTEMS INC
CIK 0001416172
Entity typeother
Related Parties
1- filerCIK 0001571214
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 8:11 PM ET
- Size
- 9.4 KB